Trial Profile
Immunogenicity and Safety of Different Sequential Schedules of Inactivated Poliomyelitis Vaccine (IMOVAX Polio(R)) Followed by Oral Poliomyelitis Vaccine in Healthy Infants in China Versus Oral Poliomyelitis Vaccine Alone.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 May 2014
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine (Primary) ; Poliovirus vaccine live oral
- Indications Poliomyelitis
- Focus Therapeutic Use
- Sponsors Sanofi Pasteur
- 22 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Nov 2011 New trial record